Rate My Professor Janice Withycombe

Janice Withycombe, PhD, RN, MN, FAAN, serves as Associate Professor in the School of Nursing at Clemson University’s College of Behavioral, Social and Health Sciences. She earned her PhD in Nursing from the University of Arizona in 2015, Master of Nursing from the University of South Carolina in 1993, and Bachelor of Science in Nursing from Clemson University in 1987. Her career includes joining Clemson in August 2019 after serving as Assistant Professor at Emory University’s Nell Hodgson Woodruff School of Nursing from 2015 to 2019. Previously, she was a Research Nurse in Pediatric Oncology and Hematology at Palmetto Health Children’s Hospital from 2002 to 2015, held management positions at Palmetto Health in homecare, hospice, and private services from 1992 to 2002, and worked as a staff nurse in pediatric intensive care and other roles starting in 1988.

Withycombe’s research specializations encompass pediatric oncology, physical activity promotion, metabolomics, patient and family education, and patient-reported outcomes. She explores relationships between physical activity, oxidative stress, and symptoms like fatigue in children receiving cancer treatment, and has contributed to instrument development and validation for pediatric measures such as PROMIS and PRO-Common Terminology Criteria for Adverse Events. As a Faculty Scholar in Clemson’s School of Health Research and immediate past Chair of the Nursing Research Committee for the Children’s Oncology Group, she advances symptom science and evidence-based practice. Notable awards include Fellow of the American Academy of Nursing (2021), South Carolina Palmetto Gold Award (2022), Early Career Researcher Award from the Association of Pediatric Hematology Oncology Nurses (2018), Transdisciplinary Training in Energetics and Cancer National Cancer Institute Fellow (2018), and March of Dimes’ Pediatric Nurse of the Year for Georgia (2017). Key publications feature “Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events” (Pediatric Blood & Cancer, 2022), “Metabolites associated with fatigue and physical activity in childhood cancer” (Biological Research for Nursing, 2022), “Metabolic Pathways Associated With Psychoneurological Symptoms Cluster in Children With Cancer Receiving Chemotherapy” (Biological Research for Nursing, 2022), and “Validation of the Caregiver Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events” (Cancer, 2021). Her contributions influence pediatric cancer clinical trials, symptom reporting, and survivorship care.